In this episode of Hearsay, CEO of OPRG, Chris Foster, joins Michael Maslansky and Lee Carter to share highlights from important new maslansky + partners research that looks at the state of the world and how people think about business today.
The “MAHA” (Make America Healthy Again) movement is no longer fringe—it’s mainstream. What started as a handful of so-called “anti-vaxxers” has exploded into a nationwide force that no healthcare communicator can afford to ignore. And it’s fundamentally reshaping how Americans think about health, wellness, and trust in medicine. If you’re in pharma communications, understanding the motivations, fears, and influence of the MAHA movement isn’t just important—it’s essential. Lee Carter shares four key steps for pharma companies to engage more productively with the MAHA movement and the public at large.
In this insightful piece by Lee Carter, the Goldilocks Principle is used to illustrate how companies can navigate today’s volatile cultural and political landscape—not by staying silent or overreacting, but by communicating with clarity, courage, and balance to ensure their message is heard and trusted.
In this insightful piece by Ben Feller, a father’s simple moment of joy with his son sparks a powerful call to reshape the way we talk about modern fatherhood.
As the Trump administration fights over the future of its tariffs in the courts, companies are anxiously considering how to deal with this massive shift in U.S. trade policy. Tariffs have already increased costs for many businesses, and they threaten the ability of some companies to survive. Many companies are asking: what’s the right language and framing to talk about tariffs in a way that protects our business without antagonizing Washington? Michael Maslansky offers some sound advice for how to respond while mitigating the risk.
In this episode of Hearsay, Lee Carter is joined by partners Keith Yazmir and Katie Cronen to unpack why communicating effectively—especially in industries like pharma—is harder than ever.
President Trump’s executive order on pharmaceutical pricing is a wake-up call. For pharma companies, the question is not whether or not to react—but how. And how pharma companies react will have a big impact on where this debate ends. Reframe the narrative right and they have a unique opportunity to shift the conversation and become champions of both innovation and accessibility. Here’s thoughtful guidance for a constructive response.
With the administration’s increased focus on pharma and healthcare, companies across these sectors need to be ready to engage and communicate their side of the story. Many companies are looking for guidance in their messaging response to the healthcare executive order and the broader policy landscape, from tariffs to MAHA initiatives. Should your company address this directly or let the industry associations take it on? Lee Carter sheds some much-needed light on this question, with the warning: if you don’t tell your story, someone else will. And it will not be to your advantage.
It’s a chaotic time in America. Trust is shattered. People are angry. From DEI and tariffs, to rising prices, excessive profits, and broken promises, people on the left and the right believe our system is broken—and that dramatic change needs to happen. And business is getting the brunt of it. Companies need to respond to shift the conversation in their favor. In this eye-opening piece, Lee Carter shares how it’s time for a new way forward, with actionable insights to help you thrive in this new environment.
In this episode, Michael Maslansky, Lee Carter, and special guest Michelle Mahony from Daggerwing, dive into the evolving role of language in business, with a special focus on internal communications and DEI.
